Efficacy and safety of the interleukin-10-fragment F8 fusion protein PF-06687234 as add-on therapy to infliximab in patients with active ulcerative colitis: a randomized, phase IIa clinical trial
白细胞介素-10片段F8融合蛋白PF-06687234作为英夫利昔单抗辅助疗法治疗活动性溃疡性结肠炎患者的疗效和安全性:一项随机IIa期临床试验
期刊:
影响因子:
doi:10.1177/17562848251410784
Schreiber, Stefan; Danese, Silvio; Vermeire, Séverine; Leong, Rupert W; Pradhan, Vivek; Singh, Ravi Shankar P; Yu, Dahong; Messing, Dean; Neubert, Hendrik; Palandra, Joe; Tehlirian, Christopher; Gale, Jeremy D